Delivery Order SPE2DB22D1106-SPE2DB25FDZR2
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,075.56, is for the delivery of VYVANSE 40 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price contract with a completion date of January 3, 2025. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.13 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $4,012.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S, a medication used to treat conditions such as attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 14, 2025 and a Firm Fixed Price pricing type. This contract award is...
This federal contract award, valued at $2,229.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 31, 2024 and utilizes a firm fixed-price pricing type. The contract is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,919.15 firm fixed-price delivery order contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication primarily used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,508.36 firm fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,818.74 fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULES 100S, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. It is not designated as a set-aside contract, indicating...
This federal contract award, valued at $1,114.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for VYVANSE 40 MG CAPSULE 100S, a medication used for treating certain mental health conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 13, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,591.70 Firm Fixed Price Delivery Order is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 18, 2025 and was awarded on February 14, 2025. It is not associated with a set-aside program....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,962.68 firm fixed-price contract is for the supply of VYVANSE 60 MG CAPSULE 100S, a medication used to treat attention deficit hyperactivity disorder (ADHD). The award has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...